Error: Could not add to watchlist. X

Danske Invest MediLife Fund

+ Watchlist
MANMEDT:FH
0.86545
EUR
0.00000
0.00%
As of 01:59:30 ET on 06/30/2015.
Volume
0
Previous Close
0.87
52Wk Range
0.58 - 0.92
1 Yr Return
53.74%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/30/2015)
0.86545
Total Assets (m EUR) (on 04/30/2015)
80.020
Inception Date
08/15/2000
Last Dividend (on 03/26/2015)
0.0355
Dividend Indicated Gross Yield
4.10%
Fund Managers
-
Front Load Fee
1.00%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.95%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Allergan plc 14.07 k 3.64 m 4.69
Biogen Inc 9.53 k 3.29 m 4.23
AbbVie Inc 54.10 k 3.11 m 4.00
Johnson & Johnson 32.56 k 2.91 m 3.75
UnitedHealth Group Inc 27.38 k 2.77 m 3.57
Alexion Pharmaceuticals Inc 17.67 k 2.72 m 3.51
Vertex Pharmaceuticals Inc 23.52 k 2.64 m 3.40
Shire PLC 35.35 k 2.62 m 3.38
Merck & Co Inc 44.23 k 2.37 m 3.05
Eagle Pharmaceuticals Inc/DE 43.06 k 2.13 m 2.75
Profile
Danske Invest MediLife is an open-end fund registered in Finland. The Fund invests in pharmaceutical, biotechnology and medical technology and equipment companies worldwide. The Fund offers potential high yield, but also above average risk. The Fund's aim is to exceed the performance of the MSCI Pharmaceuticals -index \in the long term.
ADDRESS
Hiililaiturinkuja 2
00075 Sampo Bank
Helsinki
Finland
PHONE
358-10-236-10